ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2018 American Transplant Congress

    Outcomes after HIV+ Kidney Transplant: A HOPE in Action Study

    C. Durand,1 M. Bowring,1 A. Tobian,1 D. Brown,1 N. Desai,1 S. Bagnasco,1 D. Ostrander,1 A. Redd,1 S. Huprikar,2 B. Haydel,2 S. Lerner,2 S. Florman,2 S. Chandran,3 A. Chao,3 J. Locke,4 S. Mehta,4 R. Freidman,5 N. Turgeon,5 A. Massie,1 D. Segev.1

    1JHU, Baltimore, MD; 2Mount Sinai, New York, NY; 3UCSF, San Francisco, CA; 4UAB, Birmingham; 5Emory, Atlanta.

    The HIV Organ Policy Equity (HOPE) Act allows HIV-infected donor (HIV D+) organs to be transplanted into HIV+ recipients (HIV R+) under research protocols. We…
  • 2018 American Transplant Congress

    Alemtuzumab is Associated with Higher Rates of De Novo Donor Specific Antibody (DSA) in Patients with No Pre-Transplant DSA

    N. Bath, S. Parajuli, G. Leverson, M. Jorgenson, J. Fose, T. Ellis, D. Kaufman, A. Djamali, R. Redfield.

    Surgery, University of Wisconsin, Madison, WI.

    Introduction: Basiliximab, alemtuzumab, and thymoglobulin are the most commonly used induction agents in the US. While many centers use depleting antibody induction therapy in patients…
  • 2018 American Transplant Congress

    Efficacy of At-Home Transplant Education on Transplant Knowledge and Pursuit in Low-Income and Black Dialysis Patients with Varying Educational Characteristics

    A. Waterman,1,2 J. Peipert,1,2 J. Beaumont.2

    1Division of Nephrology, David Geffen School of Medicine at UCLA, Los Angeles, CA; 2Terasaki Research Institute, Los Angeles, CA.

    The Explore Transplant @ Home (ETH) randomized controlled trial assessed the efficacy of two supplementary education strategies for kidney transplant (KT) in dialysis centers: 1)…
  • 2018 American Transplant Congress

    Chronic Antibody Mediated Rejection in Renal Allografts Shows RNA Transcript Patterns That Evolve with Stage

    A. Rosales,1 B. Adam,2 M. Mengel,2 T. Oura,1 M. Matsunami,1 T. Kawai,1 A. Cosimi,1 R. Smith,1 R. Colvin.1

    1Massachusetts General Hospital, Boston, MA; 2University of Alberta, Edmonton, AB, Canada.

    Purpose. Four stages of chronic antibody mediated rejection (CAMR) in renal allografts have been defined in humans and non-human primates (NHP), beginning with donor specific…
  • 2018 American Transplant Congress

    Identifying the Specific Causes of Kidney Allograft Loss: A Population Based Study

    C. Loheac, O. Aubert, D. VIglietti, N. Kamar, M. Delahousse, C. Lefaucheur, A. Loupy.

    Paris Translational Research Center for Organ Transplantation, Paris, France.

    Understanding the specific causes of kidney allograft loss is mandatory to improve the longevity of kidney allografts. However, the current literature is limited by the…
  • 2018 American Transplant Congress

    Frailty Assessment Pilot Study in Older Kidney Transplant Recipients

    B. Abdalla, B. Hale-Durbin, J. Schaenman, C. Lee, G. Danovitch.

    UCLA, Los Angeles, CA.

    Older patients are more often being considered for kidney transplantation, however many candidates are on the waitlist for several years. We sought to evaluate the…
  • 2018 American Transplant Congress

    Enhancement of Intrinsic Apoptosis via Bcl-2 Inhibition Promotes Induction of Robust Mixed Chimerism and Renal Allograft Tolerance without Myelosuppression in Nonhuman Primates

    T. Oura,1 A. Dehnadi,1 I. Rosales,1 H. Sasaki,1 P. Cippa,2 R. Fehr,2 A. Cosimi,1 T. Kawai.1

    1Surgery, Center for Transplantation Science, Massachusetts General Hospital, Boston, MA; 2Medicine, University of Zurich, Zurich, Switzerland.

    Background: Successful induction of mixed chimerism (MC) and renal allograft tolerance has been achieved in both nonhuman primate (NHP) and man following conditioning that included…
  • 2018 American Transplant Congress

    Tacrolimus Metabolism in Subjects with Potentially Absent CYP3A Activity

    A. Scheibner,1 R. Remmel,2 D. Schladt,3 W. Oetting,1 W. Guan,4 B. Wu,4 C. Door,5 A. Israni,5 P. Jacobson.1

    1Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, MN; 2Medicinal Chemistry, University of Minnesota, Minneapolis, MN; 3Minneapolis Medical Research Foundation, Hennepin County Medical Center, Minneapolis, MN; 4Biostatistics, University of Minnesota, Minneapolis, MN; 5Department of Medicine, Hennepin County Medical Center, Minneapolis, MN.

    Purpose: Tacrolimus (TAC) is a well-known cytochrome P450 (CYP) 3A4 and 3A5 substrate. Common single nucleotide polymorphisms (SNPs) in these genes are significantly related to…
  • 2018 American Transplant Congress

    Inflammation in Scarred Areas (i-IF/TA): Defining the Response to Standard Treatment of T Cell-Mediated Rejection in Kidney Recipients

    D. Viglietti, O. Aubert, J-.P. Duong Van Huyen, A. Loupy, C. Lefaucheur.

    Paris Translational Research Center for Organ Transplantation, Paris, France.

    The 2017 Banff meeting has focused on the importance of defining the potential role of i-IF/TA as a component of the T cell-mediated rejection (TCMR)…
  • 2018 American Transplant Congress

    HLA Eplet Mismatch and Donor Specific Antibodies in Kidney Transplantation

    S. Wan,1,2 S. Angel de Wilde,2 B. Rosales,2 S. Chadban,1,2 K. Wyburn.1,2

    1Department of Renal Medicine, Royal Prince Alfred Hospital, Sydney, Australia; 2Sydney Medical School, University of Sydney, Sydney, Australia.

    BACKGROUND: Although HLA matching improves graft survival in kidney transplant recipients (KTx), eplet mismatches provide higher resolution information, and could better predict the development of…
  • « Previous Page
  • 1
  • …
  • 326
  • 327
  • 328
  • 329
  • 330
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences